Eating nuts twice a week linked with lower risk of fatal heart attack and stroke: ESC 2019 update Hina Zahid31 Aug 2019 5:24 PM ISTParis, France: Eating nuts two or more times a week may lower the risk of fatal heart attack and stroke by 17%, revealed a study presented at European...
Screening for high LDL cholesterol in familial hypercholesterolemia may help avoid heart attack: ESC 2019 update Hina Zahid2 Sept 2019 9:01 AM ISTScreening for Heterozygous familial hypercholesterolemia may help in avoiding a heart attack is a new ESC 2019 update.Patients with familial...
Tiny wearable cameras may fine-tune self-management in heart failure patients: ESC 2019 update Hina Zahid3 Sept 2019 9:05 AM ISTTiny wearable cameras may fine-tune self-management and improve quality of life in heart failure patients: ESC 2019 updateThe ever-present devices...
Exercise reduces mortality risk in CVD patients more than in healthy people: ESC 2019 update Hina Zahid3 Sept 2019 9:00 AM ISTExercise or Increased physical activity reduces mortality risk during a six-year follow-up period for people with and without CVD, but the researchers...
Silent Killer! Anabolic-androgenic steroid use associated with ventricular dysfunction in weightlifters: ESC 2019 Update Hina Zahid3 Sept 2019 8:20 PM ISTParis, France: Anabolic-androgenic steroid use is associated with a number of worrying effects on the heart that may lead to ventricular dysfunction...
Ticagrelor or Prasugrel?? Which antiplatelet therapy is best to treat ACS Deepanjana Sarkar5 Sept 2019 7:28 PM ISTPrasugrel and ticagrelor, novel antiplatelet agents have emerged as advanced oral antiplatelet therapy for patients with Acute Coronary Syndromes...
Community-based salt substitution improves BP and hypertension control: ESC 2019 Update Hina Zahid5 Sept 2019 8:28 PM ISTSalt substitution in a community-based programme improves BP and hypertension control. A community-based salt substitution programme in Peru lowered...
Inclisiran is twice-yearly potent injectable LDL cholesterol lowering drug reveals Phase 3 clinical trial Deepanjana Sarkar8 Sept 2019 8:28 PM ISTInclisiran is new twice-yearly effective and potent injectable LDL cholesterol-lowering drug, according to a clinical trial.The results of phase 3...
Beta blockers reduce deaths in patients with moderate Kidney Dysfunction: ESC 2019 Update Deepanjana Sarkar10 Sept 2019 8:20 PM ISTParis-Beta blockers have been found effective in reducing deaths in patients with heart failure and moderate or moderately severe Kidney Dysfunction,...
